Source: Annual Congress 2013 –COPD: new markers of diseases
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. S. Sohal, S. D. Shukla, D. Reid, E. H. Walters, J. Grigg (London, United Kingdom; Hobart, Brisbane, Australia). Platelet activating factor receptor (PAFr) expression is increased in airways of COPD patients but is not attenuated by inhaled corticosteroid (ICS). Eur Respir J 2013; 42: Suppl. 57, 594

Member's Comments

No comment yet.

Related content which might interest you: Anticholinergic treatment does not affect toll-like receptor 3-induced antiviral immune response in COPD bronchial epithelial cells Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Distinct localization of estrogen receptors in lungs of severe COPD patients Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 E-cadherin (CDH-1) polymorphisms associate with airway remodeling, inflammation and FEV1 decline in asthma patients using inhaled corticosteroids (ICS) Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases Year: 2010 IL-8 and TSLP production as markers of bronchial epithelial cell activation in IL-17A mediated airway inflammation in COPD: Role of tiotropium Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung Year: 2013 COPD: Inhaled corticosteroid (ICS) and long-acting beta2-agonist (LABA) combination and oxygen saturation (OS) in patients (pts) with different plasma surfactant protein D (SP-D) level Source: International Congress 2015 – COPD: notable points Year: 2015 Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 Differential effect of fluticasone on Poly(I:C) induced TSLP secretion by bronchial epithelial cells from asthmatic children Source: International Congress 2016 – Mechanisms of disease Year: 2016 Increased expression of ADRB2, CHRM3 and glucocorticoid alpha receptor genes in blood leukocytes of COPD patients Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 COPD airway epithelium secretion attracts and activates neutrophils Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Effect of switching from high-dose inhaled corticosteroid (ICS) to low-dose ICS plus an inhaled long-acting β2-agonist on asthma control, airway inflammation and remodeling, and gene expression in airway epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 35s Year: 2003 Impaired inhibitory action of corticosteroids on chemokine expression induced by TNFalpha in airway smooth muscle (ASM) cells from patients with severe asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Glucocorticosteroid receptor (GCR) gene isoforms expression in bronchial asthma (BA) patients Source: Annual Congress 2011 - Asthma: a heterogeneous disease Year: 2011 Up-regulation of EGFR gene family in COPD patients: Correlation with airway obstruction Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 E-cadherin gene polymorphisms in asthma patients using inhaled corticosteroids Source: Eur Respir J 2011; 38: 1044-1052 Year: 2011 Altered P2 receptor expression profile in sputum cells of patients with COPD Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 The CysLT1 receptor antagonist montelukast inhibits mast cell activation induced by inhaled leukotriene E4 in subjects with asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Gene polymorphism of epidermal growth factor receptor (EGFR) and airway hyperresponsiveness (AHR) in young allergic subjects without respiratory symptoms Source: Annual Congress 2011 - Biomarkers of allergic inflammation Year: 2011 Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma Source: Eur Respir J 2002; 20: 1080-1087 Year: 2002 Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 652s Year: 2006